ZA986338B - Simethicone/anhydrous calcium phosphate compositions. - Google Patents

Simethicone/anhydrous calcium phosphate compositions.

Info

Publication number
ZA986338B
ZA986338B ZA9806338A ZA986338A ZA986338B ZA 986338 B ZA986338 B ZA 986338B ZA 9806338 A ZA9806338 A ZA 9806338A ZA 986338 A ZA986338 A ZA 986338A ZA 986338 B ZA986338 B ZA 986338B
Authority
ZA
South Africa
Prior art keywords
simethicone
calcium phosphate
anhydrous calcium
phosphate compositions
compositions
Prior art date
Application number
ZA9806338A
Other languages
English (en)
Inventor
Joseph R Luber
Glenn Madison
Gerard Mcnally
Original Assignee
Mcneil Ppc Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mcneil Ppc Inc filed Critical Mcneil Ppc Inc
Publication of ZA986338B publication Critical patent/ZA986338B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/74—Synthetic polymeric materials
    • A61K31/80—Polymers containing hetero atoms not provided for in groups A61K31/755 - A61K31/795
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/42—Phosphorus; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2009—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Inorganic Chemistry (AREA)
  • Nutrition Science (AREA)
  • Zoology (AREA)
  • Physiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
ZA9806338A 1997-07-17 1998-07-16 Simethicone/anhydrous calcium phosphate compositions. ZA986338B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US08/896,189 US6103260A (en) 1997-07-17 1997-07-17 Simethicone/anhydrous calcium phosphate compositions

Publications (1)

Publication Number Publication Date
ZA986338B true ZA986338B (en) 2000-01-17

Family

ID=25405781

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA9806338A ZA986338B (en) 1997-07-17 1998-07-16 Simethicone/anhydrous calcium phosphate compositions.

Country Status (19)

Country Link
US (1) US6103260A (fr)
EP (1) EP0891776B1 (fr)
JP (1) JPH1192387A (fr)
KR (1) KR100549355B1 (fr)
CN (1) CN1267106C (fr)
AR (1) AR013227A1 (fr)
AT (1) ATE259236T1 (fr)
AU (1) AU727271B2 (fr)
BR (1) BR9802487B1 (fr)
CZ (1) CZ294084B6 (fr)
DE (1) DE69821553T2 (fr)
DK (1) DK0891776T3 (fr)
ES (1) ES2216244T3 (fr)
HU (1) HUP9801615A3 (fr)
NZ (1) NZ330915A (fr)
PL (1) PL189988B1 (fr)
PT (1) PT891776E (fr)
RU (1) RU2216317C2 (fr)
ZA (1) ZA986338B (fr)

Families Citing this family (95)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6326384B1 (en) * 1999-08-26 2001-12-04 Robert R. Whittle Dry blend pharmaceutical unit dosage form
US6793934B1 (en) * 1999-12-08 2004-09-21 Shire Laboratories, Inc. Solid oral dosage form
KR100442174B1 (ko) * 2001-09-25 2004-07-30 (주)다산메디켐 이산화규소, 폴리소르베이트류 및디메칠폴리실록산(디메치콘, 시메치콘)을 함유하는소화기장애에 사용되는 고형의 신규의약조성물
US7838026B2 (en) 2001-09-28 2010-11-23 Mcneil-Ppc, Inc. Burst-release polymer composition and dosage forms comprising the same
US20040253312A1 (en) 2001-09-28 2004-12-16 Sowden Harry S. Immediate release dosage form comprising shell having openings therein
US7122143B2 (en) 2001-09-28 2006-10-17 Mcneil-Ppc, Inc. Methods for manufacturing dosage forms
US20040146559A1 (en) * 2002-09-28 2004-07-29 Sowden Harry S. Dosage forms having an inner core and outer shell with different shapes
US7101573B2 (en) * 2001-09-28 2006-09-05 Mcneil-Pcc, Inc. Simethicone solid oral dosage form
MXPA04002977A (es) * 2001-09-28 2005-06-20 Johnson & Johnson Forma de dosificacion que contiene una composicion de confiteria.
US20030229158A1 (en) * 2001-09-28 2003-12-11 Chen Jen Chi Polymer composition and dosage forms comprising the same
US6837696B2 (en) * 2001-09-28 2005-01-04 Mcneil-Ppc, Inc. Apparatus for manufacturing dosage forms
US6753009B2 (en) 2002-03-13 2004-06-22 Mcneil-Ppc, Inc. Soft tablet containing high molecular weight polyethylene oxide
US7169450B2 (en) * 2002-05-15 2007-01-30 Mcneil-Ppc, Inc. Enrobed core
US7807197B2 (en) * 2002-09-28 2010-10-05 Mcneil-Ppc, Inc. Composite dosage forms having an inlaid portion
RU2005108609A (ru) 2002-09-28 2006-03-10 МакНЕЙЛ-ППС, ИНК. (US) Лекарственные формы с модифицированным высвобождением, имеющие два ядра и отверстие
US7341742B2 (en) * 2002-09-30 2008-03-11 L. Perrigo Company Simethicone containing tablet composition and method
US20040109889A1 (en) * 2002-12-04 2004-06-10 Bunick Frank J. Surface treatment composition for soft substrates
TWI327913B (en) * 2003-03-12 2010-08-01 Novartis Ag Pharmaceutical composition comprising 5-methyl-2-(2'-chloro-6'-fluoroanilino)phenylacetic acid
US20040185093A1 (en) * 2003-03-18 2004-09-23 Szymczak Christopher E. Compositions containing sucralose
US20040186180A1 (en) * 2003-03-21 2004-09-23 Gelotte Cathy K. Non-steroidal anti-inflammatory drug dosing regimen
US20040265373A1 (en) * 2003-06-27 2004-12-30 David Wynn Soft tablet containing high molecular weight cellulosics
US20040265372A1 (en) * 2003-06-27 2004-12-30 David Wynn Soft tablet containing high molecular weight cellulosics
US20050069590A1 (en) * 2003-09-30 2005-03-31 Buehler Gail K. Stable suspensions for medicinal dosages
US20050074514A1 (en) * 2003-10-02 2005-04-07 Anderson Oliver B. Zero cycle molding systems, methods and apparatuses for manufacturing dosage forms
US20050095299A1 (en) * 2003-10-30 2005-05-05 Wynn David W. Controlled release analgesic suspensions
US20050095300A1 (en) * 2003-10-30 2005-05-05 Wynn David W. Controlled release analgesic suspensions
US7879354B2 (en) 2004-01-13 2011-02-01 Mcneil-Ppc, Inc. Rapidly disintegrating gelatinous coated tablets
US8067029B2 (en) * 2004-01-13 2011-11-29 Mcneil-Ppc, Inc. Rapidly disintegrating gelatinous coated tablets
US20050196442A1 (en) * 2004-03-05 2005-09-08 Huang Hai Y. Polymeric compositions and dosage forms comprising the same
US20050196448A1 (en) * 2004-03-05 2005-09-08 Hai Yong Huang Polymeric compositions and dosage forms comprising the same
US20050196447A1 (en) * 2004-03-05 2005-09-08 Huang Hai Y. Polymeric compositions and dosage forms comprising the same
US20050196446A1 (en) * 2004-03-05 2005-09-08 Huang Hai Y. Polymeric compositions and dosage forms comprising the same
WO2006026337A1 (fr) * 2004-08-25 2006-03-09 Fairfield Clinical Trials, Llc Association d’un inhibiteur de la pompe à proton et d’un antagoniste du récepteur h2 pour le traitement du reflux gastro-œsophagien
US20060062811A1 (en) * 2004-09-21 2006-03-23 Szymczak Christopher E Medicinal cooling emulsions
US20070281022A1 (en) * 2004-10-27 2007-12-06 Bunick Frank J Dosage forms having a microreliefed surface and methods and apparatus for their production
US20060087051A1 (en) * 2004-10-27 2006-04-27 Bunick Frank J Dosage forms having a microreliefed surface and methods and apparatus for their production
US20060088587A1 (en) * 2004-10-27 2006-04-27 Bunick Frank J Dosage forms having a microreliefed surface and methods and apparatus for their production
US8383159B2 (en) * 2004-10-27 2013-02-26 Mcneil-Ppc, Inc. Dosage forms having a microreliefed surface and methods and apparatus for their production
US20060088593A1 (en) * 2004-10-27 2006-04-27 Bunick Frank J Dosage forms having a microreliefed surface and methods and apparatus for their production
US20070190133A1 (en) * 2004-10-27 2007-08-16 Bunick Frank J Dosage forms having a microreliefed surface and methods and apparatus for their production
US20060088586A1 (en) * 2004-10-27 2006-04-27 Bunick Frank J Dosage forms having a microreliefed surface and methods and apparatus for their production
US8673352B2 (en) 2005-04-15 2014-03-18 Mcneil-Ppc, Inc. Modified release dosage form
US20070077300A1 (en) * 2005-09-30 2007-04-05 Wynn David W Oral compositions containing a salivation inducing agent
CO5790164A1 (es) * 2006-08-10 2007-08-31 Procaps S A Composicion farmaceutica solida que incluye en combinacion un agente regulador de la motilidad intestinal y un agente antiflatulento
BRPI0718171A2 (pt) * 2006-10-20 2013-11-26 Mcneil Ppc Inc Combinações de acetaminofeno/ibuprofeno e método para uso das mesmas
BRPI0718428A2 (pt) * 2006-10-25 2013-11-12 Mcneil Ppc Inc Composição de ibuprofeno
KR20090088913A (ko) 2006-11-21 2009-08-20 맥네일-피피씨, 인코포레이티드 개질된 방출형 진통 현탁제
US8491937B2 (en) * 2007-02-15 2013-07-23 Wyeth Llc Stability in vitamin and mineral supplements
US9833510B2 (en) * 2007-06-12 2017-12-05 Johnson & Johnson Consumer Inc. Modified release solid or semi-solid dosage forms
US20090004248A1 (en) * 2007-06-29 2009-01-01 Frank Bunick Dual portion dosage lozenge form
US20090060983A1 (en) * 2007-08-30 2009-03-05 Bunick Frank J Method And Composition For Making An Orally Disintegrating Dosage Form
BRPI0816929A2 (pt) * 2007-09-17 2015-03-17 Mcneil Ppc Inc Composições revestidas por imersão contendo copolímero de álcool polivinílico e polietileno glicol, bem como uma goma
EP2217213B1 (fr) * 2007-10-31 2017-05-24 Johnson & Johnson Consumer Inc. Forme posologique se désintégrant dans la bouche
CA2709709A1 (fr) * 2007-12-21 2009-07-09 Mcneil-Ppc, Inc. Fabrication d'un comprime
CN102014883A (zh) * 2008-01-31 2011-04-13 麦克内尔-Ppc股份有限公司 具有调释型活性成分的可食用膜条片
BRPI0906648A2 (pt) * 2008-01-31 2019-11-19 Mcneil Ppc Inc tiras de filme comestível para liberação imediata de ingredientes ativos
EP2252271B1 (fr) * 2008-02-19 2012-05-23 McNeil-PPC, Inc. Compositions revêtues par immersion contenant un amidon ayant une teneur élevée en amylose
WO2009158368A1 (fr) * 2008-06-26 2009-12-30 Mcneil-Ppc, Inc. Particules enrobées contenant des agents pharmaceutiquement actifs
AU2009268640A1 (en) 2008-07-08 2010-01-14 Hyperbranch Medical Technology, Inc. Self-contained medical applicators for multiple component formulations, and methods of use thereof
AU2009308885A1 (en) * 2008-10-31 2010-05-06 Mcneil-Ppc, Inc. Osmotic tablet with a compressed outer coating
US20100247586A1 (en) * 2009-03-27 2010-09-30 Andreas Hugerth Multi-Portion Intra-Oral Dosage Form With Organoleptic Properties
US20100330169A1 (en) * 2009-06-29 2010-12-30 Frank Bunick Pharmaceutical Tablet Containing A Liquid Filled Capsule
US8858210B2 (en) 2009-09-24 2014-10-14 Mcneil-Ppc, Inc. Manufacture of variable density dosage forms utilizing radiofrequency energy
US8807979B2 (en) * 2009-09-24 2014-08-19 Mcneil-Ppc, Inc. Machine for the manufacture of dosage forms utilizing radiofrequency energy
WO2012039788A1 (fr) 2010-09-22 2012-03-29 Mcneil-Ppc, Inc. Comprimé orodispersible multicouche et sa fabrication
US8313768B2 (en) 2009-09-24 2012-11-20 Mcneil-Ppc, Inc. Manufacture of tablet having immediate release region and sustained release region
US20110070286A1 (en) * 2009-09-24 2011-03-24 Andreas Hugerth Process for the manufacture of nicotine-comprising chewing gum and nicotine-comprising chewing gum manufactured according to said process
TWI461213B (zh) * 2009-11-05 2014-11-21 Fmc Corp 作為藥物賦形劑之微晶纖維素及磷酸鈣之組合物
AU2011306065B2 (en) 2010-09-22 2015-03-19 Mcneil-Ppc, Inc. Manufacture of tablets from energy-applied powder blend
MX2010012479A (es) * 2010-11-16 2012-05-16 Posi Visionary Solutions Llp Composicion farmaceutica de administracion oral para el tratamiento del sindrome de intestino irritable, a base de un modificador de la motilidad intestinal, un agente que previene la retencion de gases y enzimas digestivas y proceso para su preparacion.
US20150119422A1 (en) * 2011-12-14 2015-04-30 Disphar International B.V. Simethicone formulation
MX359529B (es) 2012-02-07 2018-10-01 Mcneil Ppc Inc Tabletas recubiertas de desintegración rápida.
US9233491B2 (en) 2012-05-01 2016-01-12 Johnson & Johnson Consumer Inc. Machine for production of solid dosage forms
US20130295174A1 (en) 2012-05-01 2013-11-07 Mcneil-Ppc, Inc. Tablet comprising a first and second region
US9445971B2 (en) 2012-05-01 2016-09-20 Johnson & Johnson Consumer Inc. Method of manufacturing solid dosage form
US9511028B2 (en) 2012-05-01 2016-12-06 Johnson & Johnson Consumer Inc. Orally disintegrating tablet
GB201315559D0 (en) * 2013-08-02 2013-10-16 Tate & Lyle Ingredients Sweetener compositions
GB201315558D0 (en) 2013-08-02 2013-10-16 Tate & Lyle Ingredients Sweetener compositions
US9789066B2 (en) 2014-01-10 2017-10-17 Johnson & Johnson Consumer Inc. Process for making tablet using radiofrequency and lossy coated particles
CA2937315A1 (fr) 2014-02-05 2015-08-13 Merck Sharp & Dohme Corp. Formulation de comprime pour composes actifs vis-a-vis du cgrp
WO2016114734A1 (fr) 2015-01-16 2016-07-21 Biofarma Ilaç Sanayi Ve Ticaret A. Ş. Formulation pharmaceutique de maléate de trimébutine et de siméthicone comprenant un agent acidifiant
MA41620A (fr) 2015-05-14 2018-01-09 Abdi Ibrahim Ilac Sanayi Ve Ticaret A S Composition pharmaceutique comprenant de la siméthicone et de l'otilonium
WO2016200345A1 (fr) 2015-06-12 2016-12-15 Santa Farma İlaç Sanayi̇ A. Ş. Composition pharmaceutique orale comprenant du bromure d'otilonium et de la siméthicone présentant une certaine densité en vrac et des caractéristiques de dissolution améliorées
EP3487485A2 (fr) 2016-07-19 2019-05-29 Johnson & Johnson Consumer Inc. Comprimés ayant des régions revêtues discontinues
US10583089B2 (en) 2016-07-19 2020-03-10 Johnson & Johnson Consumer Inc. Tablets having discontinuous coated regions
AU2017363357B2 (en) 2016-11-28 2023-10-05 Johnson & Johnson Consumer Inc. Process for making a coated dosage form
BR112019010671A8 (pt) 2016-11-28 2022-07-26 Currahee Holding Company Inc Composições líquidas que compreendem um agente mucoadesivo
MX2016016587A (es) * 2016-12-14 2018-06-13 Rhein Siegfried Sa De Cv Composicion mejorada de lansoprazol y simeticona y procesos para prepararla.
US10493026B2 (en) 2017-03-20 2019-12-03 Johnson & Johnson Consumer Inc. Process for making tablet using radiofrequency and lossy coated particles
AU2018273539B2 (en) 2017-05-22 2024-03-21 Johnson & Johnson Consumer Inc. Lozenge dosage form
CN107573689A (zh) * 2017-08-03 2018-01-12 江苏汉斯通药业有限公司 西甲硅油的制备方法
CN111132667A (zh) 2017-09-29 2020-05-08 强生消费者公司 固体西甲硅油颗粒及其剂型
AU2019208501A1 (en) 2018-01-22 2020-07-02 Johnson & Johnson Consumer Inc. Perforated capsules
AU2021409718A1 (en) 2020-12-22 2023-07-13 Allergan Pharmaceuticals International Limited Treatment of migraine
KR20240095472A (ko) 2021-11-16 2024-06-25 존슨 앤드 존슨 컨수머 인코포레이티드 시메티콘을 함유하는 맞춤화 가능한 투여 형태

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
USRE25205E (en) * 1960-10-10 1962-07-24 Silicone composition for the relief of
US4127650A (en) * 1975-03-31 1978-11-28 William H. Rorer, Inc. Medicinal simethicone containing composition and its method of production
US4396604A (en) * 1982-05-17 1983-08-02 Norcliff Thayer, Inc. Simethicone antacid lozenge
US4557916A (en) * 1984-10-22 1985-12-10 J. M. Huber Corporation Synthetic calcium silicates and methods of preparation
US4867989A (en) * 1986-09-09 1989-09-19 Warner-Lambert Company Chewing gum mineral supplement
US4906478A (en) * 1988-12-12 1990-03-06 Valentine Enterprises, Inc. Simethicone/calcium silicate composition
US5073384A (en) * 1989-10-19 1991-12-17 Valentine Enterprises, Inc. Maltodextrin/defoaming composition combinate
US5275822A (en) * 1989-10-19 1994-01-04 Valentine Enterprises, Inc. Defoaming composition
KR920002149A (ko) * 1990-07-03 1992-02-28 안드레아 엘. 콜비 비스테로이드계 소염제에 의해 유발된 위장 장애 증상을 완화시키기 위한 약제 조성물 및 이를 완화시키는 방법
GR1002332B (el) * 1992-05-21 1996-05-16 Mcneil-Ppc Inc. Νεες φαρμακευτικες συνθεσεις που περιεχουν σιμεθεικονη.
FR2705966B1 (fr) * 1993-06-04 1995-08-25 Dow Corning Sa Compositions antimousse utiles notamment pour le traitement de troubles gastriques.

Also Published As

Publication number Publication date
PT891776E (pt) 2004-05-31
CZ294084B6 (cs) 2004-10-13
ES2216244T3 (es) 2004-10-16
ATE259236T1 (de) 2004-02-15
DE69821553T2 (de) 2004-12-23
PL327491A1 (en) 1999-01-18
DK0891776T3 (da) 2004-05-10
CZ222198A3 (cs) 1999-02-17
NZ330915A (en) 1999-06-29
PL189988B1 (pl) 2005-10-31
BR9802487A (pt) 1999-09-08
HU9801615D0 (en) 1998-09-28
AR013227A1 (es) 2000-12-13
RU2216317C2 (ru) 2003-11-20
BR9802487B1 (pt) 2010-05-18
EP0891776A1 (fr) 1999-01-20
JPH1192387A (ja) 1999-04-06
AU727271B2 (en) 2000-12-07
KR19990013918A (ko) 1999-02-25
CN1267106C (zh) 2006-08-02
HUP9801615A2 (hu) 1999-07-28
DE69821553D1 (de) 2004-03-18
KR100549355B1 (ko) 2006-04-06
AU7508898A (en) 1999-01-28
US6103260A (en) 2000-08-15
HUP9801615A3 (en) 2000-06-28
CN1207898A (zh) 1999-02-17
EP0891776B1 (fr) 2004-02-11

Similar Documents

Publication Publication Date Title
ZA986338B (en) Simethicone/anhydrous calcium phosphate compositions.
ZA984849B (en) Compositions.
ZA982253B (en) Therapeutic compositions.
HK1021313A1 (en) Tetrahydrolipstatin containing compositions.
MXPA00003271A (es) Composiciones sensibles al agua.
GB9623026D0 (en) Anhydrous compositions
ZA984567B (en) Detergent compositions.
ZA983167B (en) Liquid antacid compositions.
GB9702238D0 (en) Compositions
ZA984218B (en) Detergent compositions.
ZA984220B (en) Detergent compositions.
ZA987797B (en) Oral compositions.
ZA9811337B (en) Acid resistant cement composition.
ZA9811502B (en) Novel composition.
ZA9810585B (en) Deodorant composition.
ZA982343B (en) Detergent compositions.
PL337037A1 (en) Phosphate-based detergent compositions
GB2331703B (en) Disinfectant compositions
IL125556A0 (en) Fertilizer composition
GB9714998D0 (en) Construction block composition
ZA984837B (en) Phosphate compounds
ZA981739B (en) Composition.
GB9705340D0 (en) Compositions
GB9703109D0 (en) Compositions
AU6427798A (en) Calcium composition